{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:38:10Z","timestamp":1790617090539,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.jaad.2015.09.064","type":"journal-article","created":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T23:46:28Z","timestamp":1454456788000},"page":"693-699.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["The effect of increasing the dose of hydroxychloroquine (HCQ) in patients with refractory cutaneous lupus erythematosus (CLE): An open-label prospective pilot study"],"prefix":"10.1016","volume":"74","author":[{"given":"Fran\u00e7ois","family":"Chasset","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Arnaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Costedoat-Chalumeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel","family":"Zahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Bessis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Franc\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaad.2015.09.064_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/jid.2014.316","article-title":"From pathogenesis, epidemiology, and genetics to definitions, diagnosis, and treatments of cutaneous lupus erythematosus and dermatomyositis: a report from the 3rd International Conference on Cutaneous Lupus Erythematosus (ICCLE) 2013","volume":"135","author":"Schultz","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2015.09.064_bib2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2230.2011.04266.x","article-title":"Hydroxychloroquine and smoking in patients with cutaneous lupus erythematosus","volume":"37","author":"Ezra","year":"2012","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2015.09.064_bib3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1756-185X.2011.01665.x","article-title":"Efficacy and safety of methotrexate in articular and cutaneous manifestations of systemic lupus erythematosus","volume":"15","author":"Islam","year":"2012","journal-title":"Int J Rheum Dis"},{"issue":"8","key":"10.1016\/j.jaad.2015.09.064_bib4","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1177\/0961203308101714","article-title":"Treatment of lupus skin involvement with quinacrine and hydroxychloroquine","volume":"18","author":"Cavazzana","year":"2009","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.jaad.2015.09.064_bib5","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1365-2133.2011.10693.x","article-title":"Thalidomide in the treatment of refractory cutaneous lupus erythematosus: prognostic factors of clinical outcome","volume":"166","author":"Cort\u00e9s-Hern\u00e1ndez","year":"2012","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2015.09.064_bib6","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/archdermatol.2011.2558","article-title":"Low blood concentration of hydroxychloroquine in patients with refractory cutaneous lupus erythematosus: a French multicenter prospective study","volume":"148","author":"Franc\u00e8s","year":"2012","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2015.09.064_bib7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ophtha.2010.11.017","article-title":"American\u00a0Academy of Ophthalmology. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy","volume":"118","author":"Marmor","year":"2011","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.jaad.2015.09.064_bib8","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/1529-0131(199902)42:2<357::AID-ANR19>3.0.CO;2-J","article-title":"Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension","volume":"42","author":"Furst","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.jaad.2015.09.064_bib9","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/jamaophthalmol.2014.3459","article-title":"The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy","volume":"132","author":"Melles","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"10.1016\/j.jaad.2015.09.064_bib10","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0161-6420(02)01168-5","article-title":"American Academy of Ophthalmology. Recommendations on\u00a0screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology","volume":"109","author":"Marmor","year":"2002","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.jaad.2015.09.064_bib11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12016-015-8469-8","article-title":"A critical review of the effects of hydroxychloroquine and chloroquine on the eye","volume":"49","author":"Costedoat-Chalumeau","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"10.1016\/j.jaad.2015.09.064_bib12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2125.1988.tb05281.x","article-title":"A dose-ranging study of the pharmacokinetics of hydroxy-chloroquine following intravenous administration to healthy volunteers","volume":"26","author":"Tett","year":"1988","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.jaad.2015.09.064_bib13","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.0022-202X.2005.23889.x","article-title":"The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus","volume":"125","author":"Albrecht","year":"2005","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2015.09.064_bib14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2133.2010.09799.x","article-title":"Revised Cutaneous Lupus\u00a0Erythematosus Disease Area and Severity Index (RCLASI): a modified outcome instrument for cutaneous lupus erythematosus","volume":"163","author":"Kuhn","year":"2010","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2015.09.064_bib15","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1002\/art.22156","article-title":"Low blood\u00a0concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic\u00a0lupus erythematosus","volume":"54","author":"Costedoat-Chalumeau","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2015.09.064_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jaut.2014.01.021","article-title":"The classification and diagnosis of\u00a0cutaneous lupus erythematosus","volume":"48-49","author":"Kuhn","year":"2014","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.jaad.2015.09.064_bib17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archdermatol.2010.435","article-title":"Development of the CLASI as a tool to measure disease severity and responsiveness to therapy in cutaneous lupus erythematosus","volume":"147","author":"Klein","year":"2011","journal-title":"Arch Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2015.09.064_bib18","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.jaad.2015.09.064_bib19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.berh.2013.07.001","article-title":"Adherence to treatment in systemic lupus erythematosus patients","volume":"27","author":"Costedoat-Chalumeau","year":"2013","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"11","key":"10.1016\/j.jaad.2015.09.064_bib20","first-page":"1874","article-title":"Concentration-effect relationship of hydroxychloroquine in rheumatoid arthritis\u2013a cross sectional study","volume":"20","author":"Tett","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2015.09.064_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1196\/annals.1422.005","article-title":"Blood concentrations of hydroxychloroquine and its desethyl derivative correlate negatively with the percentage of CD45RO+ cells among CD4+ lymphocytes in hydroxychloroquine-treated lupus patients","volume":"1108","author":"Sailler","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaad.2015.09.064_bib22","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1002\/art.39194","article-title":"Determinants of hydroxychloroquine blood concentration variation in systemic lupus erythematosus","volume":"67","author":"Jallouli","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1016\/j.jaad.2015.09.064_bib23","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1136\/annrheumdis-2012-202322","article-title":"Hydroxychloroquine in systemic lupus erythematosus: results of a French multicenter controlled trial (PLUS Study)","volume":"72","author":"Costedoat-Chalumeau","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.jaad.2015.09.064_bib24","first-page":"95","article-title":"Long-term evaluation of antimalarials in a Dutch SLE cohort: intolerance and other\u00a0reasons for non-use","volume":"32","author":"Tsang-A-Sjoe","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.jaad.2015.09.064_bib25","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/acr.20133","article-title":"Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.jaad.2015.09.064_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10633-008-9130-0","article-title":"Using multifocal ERG ring ratios to detect and follow Plaquenil retinal toxicity: a review: review of mfERG ring ratios in Plaquenil toxicity","volume":"118","author":"Lyons","year":"2009","journal-title":"Doc Ophthalmol Adv Ophthalmol"},{"issue":"4","key":"10.1016\/j.jaad.2015.09.064_bib27","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0181-5512(04)96142-6","article-title":"Analysis of 925 patients on long-term hydroxychloroquine or chloroquine treatment: results of ophthalmological screening [in French]","volume":"27","author":"Ingster-Moati","year":"2004","journal-title":"J Fr Ophtalmol"},{"issue":"3","key":"10.1016\/j.jaad.2015.09.064_bib28","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/art.38243","article-title":"Determining adherence to therapeutic regimens in patients with chronic illness: comment on the article by Waimann et\u00a0al","volume":"66","author":"Costedoat-Chalumeau","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.jaad.2015.09.064_bib29","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1016\/j.jaad.2010.06.018","article-title":"Cutaneous lupus erythematosus: update of therapeutic options part I","volume":"65","author":"Kuhn","year":"2011","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962215022860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962215022860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:38:02Z","timestamp":1759271882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962215022860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0190962215022860"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2015.09.064","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of increasing the dose of hydroxychloroquine (HCQ) in patients with refractory cutaneous lupus erythematosus (CLE): An open-label prospective pilot study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2015.09.064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}